JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
46 hedge funds and large institutions have $20.1M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
46
Holding in Top 10
–
Calls
$167K
Puts
$4K
Top Buyers
| 1 | +$966K | |
| 2 | +$627K | |
| 3 | +$168K | |
| 4 |
Renaissance Technologies
New York
|
+$91.6K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$82K |
Top Sellers
| 1 | -$894K | |
| 2 | -$508K | |
| 3 | -$478K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$147K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$138K |